To better understand the stage(s) of differentiation reached by B-type chronic lymphocytic leukemia (B-CLL) cells and to gain insight into the potential role of antigenic stimulation in the development and diversification of these cells, we analyzed the rearranged VH genes expressed by 83 B-CLL cells (64 IgM+ and 19 non-IgM+). Our results confirm and extend the observations of a bias in the use of certain VH, D, and JH genes among B-CLL cells. In addition, they indicate that the VH genes of approximately 50% of the IgM+ B-CLL cells and approximately 75% of the non-IgM+ B-CLL cells can exhibit somatic mutations. The presence of mutation varies according to the VH family expressed by the B-CLL cell (VH3 expressers displaying more mutation than VH1 and VH4 expressers). In addition, the extent of mutation can be sizeable with approximately 32% of the IgM+ cases and approximately 68% of the non-IgM+ cases differing by > 5% from the most similar germline gene. Approximately 20% of the mutated VH genes display replacement mutations in a pattern consistent with antigen selection. However, CDR3 characteristics (D and JH gene use and association and HCDR3 length, composition, and charge) suggest that selection for distinct B cell receptors (BCR) occurs in many more B-CLL cells. Based on these data, we suggest three prototypic BCR, representing the VH genes […] Research Article
Introduction
Over the past decade, there has been considerable interest and controversy about the immunobiology of the B cell clone that is overexpanded in B-type chronic lymphocytic leukemia (B-CLL). 1 In particular, two questions have been stressed: whether B-CLL cells have experienced antigenic stimulation and whether antigenic experience, if encountered, influences the development and diversification of these cells and their Ig variable region (V) genes.
Several groups, including our own, have attempted to address these questions by analyzing the expressed V gene repertoire of B-CLL cells. Because V gene repertoires are influenced by apparent combinatorial, expression, and selection biases (1) (2) (3) (4) that occur at various stages of B cell differentiation and in distinct B cell subsets (5) (6) (7) , it is best to compare V gene analyses with B cells of a similar subset. In this regard, as B-CLL cells almost invariably express the CD5 antigen, it has been presumed that their V gene use and mutation frequency would resemble those of human CD5 ϩ B cells (8) and their mouse homologues (9) . Specifically, it has been assumed that B-CLL cells would accumulate little, if any, somatic mutation. This notion has been supported by several studies (10) (11) (12) (13) (14) (15) (16) (17) and challenged by others (18) (19) (20) (21) (22) .
In the present study, we have analyzed the V H gene sequences of a large cohort of IgM-expressing and non-IgMexpressing B-CLL cases. The results of these studies confirm that V H gene use among B-CLL cells is not random. They also indicate that these V H genes frequently undergo somatic mutation, although mutation frequencies vary according to the V H family expressed by the B-CLL cell. Furthermore, although only a small subset of these somatically mutated V H gene sequences display replacement mutations in a pattern typical of antigen selection, other findings (e.g., complementarity-determining region[CDR]3 characteristics) suggest that selection for distinct subsets of surface membrane Ig receptors has occurred in many of these cells. These findings indicate that many B-CLL cells are derived from previously stimulated CD5 ϩ B cells. 
Methods

/CD19
ϩ B cells expressing IgG or IgA were also analyzed; some of these sequences were described previously (22) . PBMC from these patients, obtained from anticoagulated venous blood by density gradient centrifugation (Fi-coll-Paque; Pharmacia LKB Biotechnology, Piscataway, NJ), were used either immediately or after thawing samples that had been cryopreserved with a programmable cell freezing machine (CryoMed, Mt. Clemens, MI).
cDNA prepared from these B-CLL samples were screened for expression of a dominant V H family (representing that of the B-CLL clone) by standard PCR and, in some cases, by ELISA-PCR. In five of the IgM-expressing cases, the ELISA-PCR revealed equal expression of two different V H families and, therefore, these samples were not analyzed further. These cases may represent B-CLL cells that lack allelic exclusion, as recently reported by Rassenti et al (23) .
Preparation of RNA and cDNA synthesis. Total RNA was isolated from PBMC using Ultraspec RNA (Biotecx Laboratories, Houston, TX) according to the manufacturer's instructions. 1 g of RNA was reverse transcribed to cDNA using 200 U of M-MLV reverse transcriptase (GIBCO BRL, Life Technologies, Grand Island, NY), 1 U of RNase inhibitor (5 Prime 3 Prime, Boulder, CO) and 20 pmol of oligo dT primer in a total volume of 20 l. Reactions were carried out at 42 Њ C for 1 h, heated at 65 Њ C for 10 min to stop the reactions, and then diluted to a final volume of 100 l.
PCR conditions for V H family assignment and cDNA sequencing. To determine the V H gene family used by the B-CLL cells, 2 l of cDNA were amplified using a sense V H family-specific framework region (FR) primer in conjunction with the appropriate antisense C H primer (Table I ). The reactions were carried out in 50 l using 20 pmol of each primer and cycled with a 9600 GeneAmp System (Perkin Elmer Cetus, Emeryville, CA) as follows: denaturation at 94 Њ C for 45 s; annealing at 65 Њ C for 45 s; and extension at 72 Њ C for 45 s. After 35 cycles, extension was continued for an additional 10 min. In certain instances, the V H family expressed by the B-CLL cells was confirmed by ELISA-PCR as previously described (24) .
V H gene DNA sequences were determined by reamplifying 5 l of the original cDNA using the appropriate V H leader and C H primers (Table I) . These reactions were carried out as follows: denaturation at 94 Њ C for 45 s; annealing at 62 Њ C for 30 s; and extension at 72 Њ C for 45 s. After 30-32 cycles, extension was continued for an additional 10 min. PCR products were sequenced directly after purification with Wizard PCR Preps (Promega, Madison, WI) using an automated sequenator (Applied Biosystems, Foster City, CA). In some instances where mutations were detected, an independent PCR product was generated. This product was then either sequenced directly or cloned into TA vector (Invitrogen, San Diego, CA), processed using Wizard minipreps (Promega), and sequenced using M13 forward and reverse primers.
Analyses of V H , D, and J H sequences. Sequences were compared with those in the V BASE sequence directory (25) using MacVector software, version 6.0 (Eastern Kodak Co., New Haven, CT). In those instances where a Ͼ 1% deviation from a germline sequence was found in an expressed V H gene, the algorithm of Chang and Casali (26) was used to determine whether "antigen selection" of the replacement (R) mutations had occurred, taking into account the inherent susceptibility of CDR to R mutations. Thus, the expected number of R mutations in CDR and FR was calculated using the formula R ϭ n ϫ CDR Rf (or FR Rf ) ϫ CDRrel (or FRrel ). Where n is the total number of observed mutations, Rf is the replacement frequency inherent to the CDR or FR, and CDRrel and FRrel are the relative sizes of the segments. A binomial probability model was used to evaluate whether the excess of R mutations in CDR or the scarcity in FR was due to chance (26) .
The criteria of Corbett et al. (i.e., the requirement for 10 consecutive nucleotides of identity [27] ) were used to assign members of the longer D gene families (D2 and D3); for members of the shorter D families (D1, D3, D4, D5, D6, D7), a requirement for seven consecutive nucleotides and no more than two differences was used. The DIR segments and the "minor" D segments were eliminated from these analyses as suggested (27) . Reading frames of the D segments were categorized as yielding either a stop codon, a hydrophilic segment, or a hydrophobic segment (27, 28) .
Analyses of HCDR3 rearrangements. HCDR3 length was determined by counting the number of amino acids (aa) between position 94 at the end of FR3 (usually two aa downstream of the conserved cystine) and position 102 at the beginning of FR4 (a conserved tryptophan in all J H segments). Acidic and basic aa and HCDR3 charge, as defined by an estimated pI, were determined using the MacVector software programs. Overall, the most frequently encountered gene was V H 4-34 ( n ϭ 15), which represented 18.1% of all the genes detected and 60% of the V H 4 genes (Tables II and III) . The distribution of 4-34 among the V H 4 genes of the IgM ϩ group was 52.9% and of the non-IgM ϩ group, 75%. The next two most frequently found genes were V H 3-07 ( n ϭ 10) and V H 1-69 (n ϭ 6), which comprised 12.1 and 7.2% of the total and 31.3 and 30.0% of their respective families. These two genes were found almost exclusively in the IgM-expressing group. Several other genes were found in multiple cases: 1-02 (n ϭ 5), 1-18 (n ϭ 4), 1-03 (n ϭ 3), 3-23 (n ϭ 4), 3-30 (n ϭ 3), 4-39 (n ϭ 4), and 4-59 (n ϭ 3). Each of these was represented in both the IgM ϩ and the non-IgM ϩ groups, except for 4-59 which was to V H family and specific V H gene use (Tables II and III) . These differences were most obvious among the IgM ϩ samples. Thus, 66.7% of the V H 3 genes displayed 2.0% or more mutations, whereas only 33.3% of the V H 1 genes differed by Ͼ 2% (P Ͻ 0.005; Mann Whitney Test). Furthermore, 45.8% of the V H 3 genes displayed Ͼ 5% difference in contrast to only 11.1% of the V H 1 genes. This difference was more striking when the two most frequently encountered genes in these two families (3-07 and 1-69) were compared. Thus, 88.9% of the 3-07 genes differed by 2%, whereas only 16.7% of the 1-69 genes had this level of difference (P Ͻ 0.005; Mann Whitney test). Similarly, 77.8% of the 3-07 genes differed by Ͼ 5%, whereas none of the 1-69 genes had Ͼ 5% mutations. 41% of the V H 4 genes of the IgM ϩ group displayed 2% or more mutation, and the most frequently encountered gene, 4-34, was mutated in 55.6% of the cases.
Results
Differences in the level of mutations among the various V H families were also seen in the non-IgM ϩ group, although it was less obvious due to the lower number of cases studied. Thus, 87.5% (7/8) of the V H 3-and 75% (6/8) of the V H 4-expressing cases exhibited 2% or greater difference from their germline counterparts (Tables II and III) . Indeed, in every case but one (CLL No. 183), these B cells displayed Ն 5% difference. Furthermore, in 100% of the non-IgM ϩ cases, the 4-34 gene was mutated. Remarkably, the V H 4-39-expressing cases exhibited virtually no mutations in both the IgM ϩ and the non-IgM ϩ settings.
D segment use and reading frame. We were able to identify D genes in 50.6% (42/83) of the B-CLL cases examined (Tables II and III) . Gene assignments were made more readily for the IgM-expressing B-CLL cells than for the isotypeswitched, non-IgM ϩ cases; indeed, in only seven of the latter cases was D segment identification possible.
Among the 35 IgM ϩ cases with identifiable D segments, genes of the D3 family were found most frequently (47.6%), followed by D6 (16.7%) and D2 (14.3%) family genes. Among the non-IgM ϩ cases, genes of these three D families were used in similar proportions. D3 gene use was most frequent among the V H 3-expressing cells (66.7%) and was similar among the V H 1-and V H 4-expressing cases (46.2% and 41.2%, respectively). The most frequently used D3 segment was D3-3 (previously called DXP4), which was found in 26.2% of the identifiable D genes (11/42 cases) and in 50% of those cases expressing the V H 1-69 gene. In general, D segments were ex- *Genes identified by two-number code with first number indicating the family, and, the second, the relative position in the locus from V H to J H (27, 29) . N.A.: not assignable. ‡ Calculated according to Chang and Casali using a binomial probability model to evaluate whether the excess of R mutations in CDR or the scarcity in FR was due to chance (26) . § Denotes statistically significant difference (P Ͻ 0.05). Tables II and III) (Tables II and III) . This value did not differ significantly between the IgM ϩ (15.14) and non-IgM ϩ (15.05) samples. When CDR3 length was analyzed in relation to the V H family incorporated into the rearranged gene, some differences were seen (V H 4: 16.84; V H 1: 15.3; V H 3: 14.31). However, when CDR3 length was compared among the most frequently used genes in these families, these differences were more striking. Thus, the 3-07 gene had an average length of 12.80, considerably shorter than the composite average of 15.11 aa. In contrast, the average length among the 4-34-expressing B-CLL cells was longer (17.0 aa). Furthermore, these 4-34-expressing cells could be divided into two categories: those with CDR3 lengths longer than the average (20.11; n ϭ 9) that usually contained a J H 6 or J H 5 segment, and those shorter than the average (12.33; n ϭ 6) that usually contained a J H 4 segment. Finally, the CDR3 lengths among the 1-69-expressing B-CLL cells were longer than the average (16.33 versus 15.11).
CDR3 composition and charge. The HCDR3 of the IgM ϩ group frequently contained relatively long stretches of tyrosines at their 3Ј ends coded for by the J H 6 segment (Table  II) . Among the B cells expressing V H 1 genes, these germline residues were altered only negligibly by somatic events. In contrast, these J H 6 sequences were altered appreciably in three of seven B-CLL cells using V H 3 genes (Nos. 027, 066, and 081), and three of six using V H 4 genes (Nos. 023, 025, and 139). This was also reflected in two of the five non-IgM ϩ B-CLL cells using V H 3 genes (Nos. 040 and 075) and all of those using V H 4 genes (Table III) .
In the absence of charged residues, rearranged HCDR3 usually have estimated pI values of 5.50 (e.g., CLL Nos. 020, 018, and 093; Table II ). However, due to the presence of D and J H segments that code for negatively charged residues (e.g., aspartic acid: D), most of the IgM ϩ B-CLL HCDR3 segments were more acidic with estimated pI values as low as 3.06 (e.g., CLL Nos. 047, 038, 056, and 064; Table II ). In only rare instances did positively charged residues offset this bias and re- 
Discussion
The non-random use of gene segments, the presence and extent of mutation, and the apparent constraints in HCDR3 structure observed in these cases provide further insights into the stage of maturation and the potential role of antigen stimulation in the evolution of these leukemic cells.
Gene use. To improve the power of these comparisons, we combined our findings for IgM ϩ B-CLL cells with those from other B-CLL studies (21, (30) (31) (32) (33) (34) (35) (36) (37) (38) and then compared these data with those for normal adult CD5 ϩ blood B cells (39). With this approach, it became apparent that V H gene family use was not comparable to that in the normal repertoire; rather, there was a statistically significant increase in V H 1 gene expression and a statistically significant decrease in V H 3 expression in B-CLL (Fig. 1) . J H family use among the pooled IgM ϩ B-CLL cells was not different from that of the normal CD5 ϩ B cell repertoire (data not shown).
V H 4-34, 3-07, and 1-69 were the most commonly expressed V H genes in our B-CLL patients. Although neither 4-34 nor 3-07 were identified as dominant genes in several previous surveys of CLL patients (17, 40 ; reviewed in reference 41), the 4-34 gene has been found in virtually all cases of cold agglutinin disease (42) (43) (44) , frequently in diffuse large cell lymphoma (45) and autoimmune disorders (46) , and virtually never in multiple myeloma (40, 47) . Interestingly, when we combine our B-CLL cases with those in the literature (21, (30) (31) (32) (33) (34) (35) (36) (37) (38) , the frequency of V H 4-34 and 3-07 expression matches that in the normal adult CD5 ϩ repertoire, although there is a statistically significant overrepresentation of the V H 1-69 gene (Fig. 2) . This latter finding confirms studies of Kipps, Carson, and coworkers, who have indicated the prominence of the 1-69 gene (31) and some of its alleles (48) in B-CLL. Although several other V H 1 and V H 3 genes (e.g., 1-02, 1-18, and 3-23) were found often in the combined B-CLL repertoire, their expression did not differ significantly from the normal. Significant underrepresentations were found for the V H 3-30, V H 3-30.3, and V H 3-33 genes (Fig. 2) , which may be responsible for the decreased use of V H 3 genes illustrated in Fig. 1 .
However, all of these comparisons need to be evaluated with caution because of the limited numbers of normal CD5 ϩ and CD5
Ϫ blood B cell sequences that are presently available in the literature for comparison. Indeed, because of this relative dearth of data, we have used the V H sequences of 144 individual CD5
ϩ blood B cells from two normal adults (39). In addition, genetic differences in gene copy numbers may be important factors in determining gene expression. This may be especially relevant as it has been reported that copies of the V H 1-69 and 3-23 genes, which are frequently found in B-CLL cells, and the V H 3-30 genes, which we have found underrepresented in this study, vary among individuals (49) (50) (51) .
J H segment use differed among the three most frequently encountered genes in that ‫ف‬ 90% of the V H 3-07 genes were associated with a J H 4 segment, whereas ‫ف‬ 50% of the V H 1-69 and V H 4-34 genes were associated with a J H 6 segment. D3 family genes were found most frequently in B-CLL cells (47.6%), followed by D6 (16.7%) and D2 (14.3%) family genes. These percentages are very similar to those recently identified in 451 rearranged HCDR3 from antibodies in the databases (27) . The individual D segment used most frequently in our cohort of B-CLL cells was D3-3 which was present in ‫ف‬ 26% of the identifiable D segments, a frequency that is almost threefold more than that found in the 451 normal sequences mentioned above (26.2 versus 9.6%). It has been reported (48) that V H 1-69 ϩ B-CLL cells frequently use the D3-3 (DXP4) segment. In our cases, 50% of the 1-69 genes were linked with this D gene. Finally, D segment expression was markedly biased in favor of hydrophilic reading frames, especially in the non-IgM ϩ group. This finding is consistent with the normal adult B cell repertoire (27, 28) .
Somatic mutation. Approximately 57% of the B-CLL V H gene sequences determined in this study were mutated. Indeed, we found mutations Ն 2% in 50.8% of the IgM ϩ B-CLL cells and mutations Ͼ 5% in 31.8% of these patients. An even higher percentage of the isotype-switched B-CLL cells exhibited these levels of mutation (72.2 and 66.7%, respectively).
Although the percentage of IgM ϩ B-CLL cells expressing mutations in the 2-5% range was similar to that reported for normal CD5
ϩ blood B cells (18.1 versus 19.1%; [39]), the percentage of B-CLL cells expressing mutations in the Ͼ 5% range was significantly different (P Ͻ 0.000001) from these normal CD5 ϩ B cells. Indeed, there were ten times as many cases of IgM ϩ CD5 ϩ B-CLL with mutations Ͼ 5% than in the normal (31.8 versus 3.5%). Surprisingly, this frequency even exceeded that reported for circulating CD5 Ϫ B cells (31.8 versus 17.6%). These latter comparisons are presented graphically in Fig. 3 . ϩ B-CLL cells had Ͻ 99% similarity to a V H 1-69 allele. This V H family-related difference in mutation may explain, in part, the discrepancies about V H gene mutation reported in other B-CLL studies, as cohorts with disproportionate numbers of either V H 1-or V H 3-expressing cases would likely yield conflicting results. A further confounding issue may be the fact that certain B-CLL cells can productively express two V H genes, which can differ in the presence and extent of mutation (23) .
B cells with receptors that have been selected by antigen often display a higher frequency of R mutations in the CDR than in the FR (52, 53) . However, when assessing the possibility of antigen selection, the inherent susceptibility of the progenitor germline gene to aa replacement needs to be considered. Based on the algorithm of Chang and Casali that incorporates these considerations (26) , 20% of our B-CLL cells demonstrate antigen selection of R mutations (noted by § in Tables II and III) .
However, it is important to recognize that such algorithms are statistical approaches that are unable to account for all aspects of "selection biology" and, therefore, may not always accurately reflect the influences of antigen. For example, in some instances, high affinity antigen binding may depend on only one or a few critical amino acids (54) (55) (56) . In these instances, the occurrence of an "advantageous" mutation would permit survival and positive selection of the mutating B cells. If, however, some of these positively selected, mutated B cells subsequently accumulate additional mutations outside of the CDR that do not alter selection by antigen, these "neutral" mutations might then result in an algorithmic determination that suggests statistical insignificance, albeit in the setting of definite biological significance. Furthermore, recent studies suggest that R mutations located outside of the CDR can enhance antigen binding (57) , a fact that these algorithms by design cannot consider. Conversely, antigen selection could favor the preservation of certain residues. For example, certain portions of the FR are important for superantigen binding (58, 59 ) and these need to be preserved to permit superantigen-mediated selection and rescue. Indeed, in this study, 61.7% (29/47) of the cases exhibited statistically significant preservations of FR sequences (Tables II and III , marked with §). Preservation of FR integrity is consistent with the necessity for B cells to maintain an intact B cell receptor (60) . Finally, these algorithms cannot take into account the structure of the H and L CDR3, the regions which have the most intimate contact with antigen. CDR3 characteristics. We were able to define three HCDR3 categories among our B-CLL cases based on differences in length, aa composition, and charge. Each of these varied in a V H family-related manner. First, the CDR3 length of V H 4-expressing B-CLL cells was greater than in V H 1-expressing B cells and this was in turn greater than in V H 3-expressing cells. This was most obvious when comparing the 3-07 (12.56 aa), 1-69 (16.33 aa), and 4-34 (17.0 aa) genes. The 4-34 genes, furthermore, could be divided into two categories: those with CDR3 lengths longer than average (20.11) and those shorter than average (12.33) . When our IgM ϩ cases were pooled with those available in GenBank/EMBL/DDBJ, these V H family-related hierarchies of CDR3 length were just as apparent and, in some instances, reached statistical significance (e.g., 3-07 versus 1-69: P Ͻ 0.05). In most cases, the short CDR3 segments of the V H 3 group and the shorter V H 4-34 subgroup contained a J H 4 segment, whereas the V H 1 group and the longer 4-34 subgroup contained a J H 6 or J H 5 segment.
Second, members of the V H 1 family frequently contained long stretches of tyrosines coded for by the J H 6 segment that were only minimally somatically altered. This was in contrast to most B-CLL cells using V H 3 genes and certain B-CLL cells using V H 4 genes, which had shorter CDR3 that frequently used a significantly altered J H 4 gene.
Finally, these differences in J H gene association resulted in a V H family-related hierarchy in charge (V H 1, V H 4, and V H 3) that, again, was most easily recognized by inspecting the V H 1-69 (pI: 3.53), 4-34 (pI: 4.37), and 3-07 (pI: 5.89) genes of the IgM ϩ group. Among the non-IgM ϩ group, CDR3 charge was much less acidic, often exceeding a value of 5.50.
We believe that these V H family-and gene-related differences in HCDR3 reflect selection for specific structural motifs that facilitate antigen binding. If so, many more than 20% of the IgM ϩ B-CLL cells would have been selected for antigen binding. However, the stage(s) of B cell development at which these selections occur is not clear at this point.
Receptor prototypes. Taken together, these studies suggest prototypic rearranged H chain variable region genes in B-CLL cells (Fig. 4) . Thus, V H 1 sequences, exemplified by the 1-69-expressing B-CLL cells, remain predominantly unmutated and frequently associated with D3 (3-3) and J H 6 segments. This results in a highly acidic HCDR3 that is slightly longer than the average. V H 3 sequences, exemplified by the 3-07-expressing B-CLLs, frequently accumulate numerous mutations and associate with D3 and J H 4 genes. These receptors have a CDR3 that is shorter and considerably less acidic than the V H 1 prototype. Finally, V H 4 sequences, exemplified by the 4-34-expressing CLLs, accumulate mutations in ‫ف‬ 50% of the cases. Because these receptors use either a J H 4 or J H 6 gene, their CDR3 are either shorter, like the V H 3 group, or longer, like the V H 1 group. In addition, they tend to be slightly less acidic than the V H 1 group.
It is unclear at this juncture whether these prototypes represent features unique to B-CLL cells or are shared with B cells of the normal adult or aging repertoire. Although we have been able to collect data on 188 B-CLL cases by combining our data with those in published articles and in GenBank/ EMBL/DDBJ (21, (30) (31) (32) (33) (34) (35) (36) (37) (38) , a coordinated compilation of both B-CLL gene sequences and normal B cell subset sequences will permit more definitive answers to these questions.
Maturation stage(s) of B-CLL cells.
Finally, based on the presence of somatic mutations, it seems incontrovertible that ‫ف‬ 50% of IgM ϩ B-CLL cells and ‫ف‬ 75% of non-IgM ϩ cells have been previously stimulated by antigen. Therefore, these cells should be considered "experienced" or "memory" CD5 ϩ B cell progeny. This conclusion is in line with those of Schroeder and Dighiero, who previously compared the sequences of a series of B-CLL cases (21) , and with the observations that IgM ϩ B-CLL cells can undergo intraclonal isotype class switching (61) (62) (63) (64) , a process that suggests clonal maturation.
However, what about those B-CLL cells that do not display V H gene mutations? Should these be considered virgin B cells or B cells driven by antigens that cannot induce somatic mutations (e.g., autoantigens) or antigens that select for unmutated V H sequences (e.g., superantigens) and/or distinct CDR3 characteristics (certain exo-or autoantigens)? Based on the overuse of specific V H , D, and J H genes, and the apparent constraints on HCDR3 structure, we favor the hypothesis that these cells also have been antigen driven and represent memory cells. However, we cannot eliminate the possibility that these receptor restrictions are developmental and represent selections that have occurred before exiting the bone marrow, thus making these virgin B cells with albeit developmentally restricted receptor structures.
